About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Brain Cancer Clinical Trials in Houston | 138 Studies

Clinical Trials Brain CancerHouston

Brain Cancer Clinical Trials in Houston

Find 138 clinical trials for brain cancer near Houston, Texas. Connect with research centers in your area.

All Brain Cancer trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-100 of 138 trials

CompletedPhase I Study of APX005M in Pediatric Central Nervous System TumorsThis phase I trial studies the side effects and best dose of APX005M in treating younger patients with primary malignant central nervous system tumor that is growing, spreading…NCT03389802·Los Angeles, California and 10 others Active not recruitingA Study of Berubicin in Adult Subjects With Recurrent Glioblastoma MultiformeThis is an open-label, multicenter, randomized, parallel, 2-arm, efficacy and safety study.NCT04762069·Little Rock, Arkansas and 47 others

Brain Cancer Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedStudy of 4-Demethyl-4-cholesteryloxycarbonylpenclome (DM-CHOC-PEN) in Patients With Brain TumorsDM-CHOC-PEN is a polychlorinated pyridine cholesteryl carbonate that has demonstrated antineoplastic activities in patients with advanced cancers - melanoma, lung, breast and…NCT02038218·New Orleans, Louisiana and 2 others

CompletedBevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or GliosarcomaThis randomized phase II trial is studying the side effects and how well giving bevacizumab together with irinotecan or temozolomide works in treating patients with recurrent or…NCT00433381·Mobile, Alabama and 92 others

TerminatedStudy to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM SubjectsThe purpose of this study is to assess the safety and tolerability of VBI-1901 in subjects with recurrent malignant gliomas (glioblastoma, or GBM).NCT03382977·Irvine, California and 11 others

TerminatedDasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed GlioblastomaPhase I: Primary Objectives: -To define the maximum tolerated dose (MTD) of dasatinib (Sprycel) with radiotherapy (RT) and 6 weeks of concomitant temozolomide (TMZ) administered…NCT00895960·Houston, Texas

CompletedStudy of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent SettingThe purpose of this phase 2, two arm, biomarker-driven study is to determine if treatment of O-6-methylguanine-DNA methyltransferase (MGMT) unmethylated glioblastoma with VAL-083…NCT02717962·Houston, Texas

TerminatedNeoadjuvant and Adjuvant Fenretinide Compared With Adjuvant Fenretinide Alone in Treating Patients Who Are Undergoing Surgical Resection For Recurrent Glioblastoma MultiformeThis randomized phase II trial is studying how well neoadjuvant and adjuvant fenretinide works compared to adjuvant fenretinide alone in treating patients who are undergoing…NCT00075491·Houston, Texas

CompletedVNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain TumorsRATIONALE: Drugs used in chemotherapy, such as VNP40101M, work in different ways to stop tumor cells from dividing so they stop growing or die.NCT00098761·San Francisco, California and 9 others

TerminatedPalbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System TumorsThis phase I trial studies the side effects and best dose of palbociclib isethionate in treating younger patients with central nervous system tumors that have grown, come back, or…NCT02255461·Los Angeles, California and 10 others

CompletedBevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or GliosarcomaRATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread.NCT00720356·Los Angeles, California and 8 others

CompletedValproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine GliomaCurrently, there are few effective treatments for the following aggressive brain tumors: glioblastoma multiforme, anaplastic astrocytoma, gliomatosis cerebri, gliosarcoma, or…NCT00879437·Oklahoma City, Oklahoma and 5 others

CompletedTemozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant GliomaRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00006025·Los Angeles, California and 8 others

TerminatedImatinib Mesylate With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed or Recurrent GliomaPhase I/II trial to estimate the maximum tolerated dose of imatinib mesylate in newly diagnosed brain stem gliomas and recurrent high grade gliomas and to assess the effectiveness…NCT00021229·San Francisco, California and 9 others

CompletedThe PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma MultiformeThe purpose of the PRECISE trial is to determine whether overall survival duration, safety, and quality of life are improved for patients treated with IL13-PE38QQR compared to…NCT00076986·Birmingham, Alabama and 59 others

CompletedCMV-specific Cytotoxic T Lymphocytes Expressing CAR Targeting HER2 in Patients With GBMThis study is for patients that have a type of brain cancer called glioblastoma multiforme (GBM). The body has different ways of fighting infection and disease.NCT01109095·Houston, Texas and 1 other

Active not recruitingDose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and SarcomasThe study evaluates CLR 131 in children, adolescents, and young adults with relapsed or refractory malignant solid tumors and lymphoma and recurrent or refractory malignant brain…NCT03478462·Palo Alto, California and 7 others

UnknownCombination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain TumorsRATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.NCT00392886·Phoenix, Arizona and 36 others

CompletedSU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation TherapyRATIONALE: SU5416 may stop the growth of astrocytoma or glioma by stopping blood flow to the tumor.NCT00004868·Los Angeles, California and 11 others

CompletedVaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeRATIONALE: Vaccines made from a peptide may help the body build an effective immune response to kill tumor cells.NCT00643097·Durham, North Carolina and 1 other

PreviousPage 5 of 7Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia